000 01176nam##2200265za#4500
0019.645764
003CaOODSP
00520200330131020
007ta
008150407|1995||||xxc|||||     f|0| 0 eng|d
020 |a0-662-21711-X
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH42-2/66-1995E
1101 |aCanada.|bHealth Canada. |bDrugs Directorate.
24514|aThe role of surrogate markers of HIV infection / |cby C. M. Tsoukas.
260 |aOttawa - Ontario : |bHealth Canada. |c1995.
300 |a47p. : |breferences, tables ; |c28 cm.
500 |aContents: Introduction.--Pathophysiology.--Serologic T cell activation markers.--Serologic B cell activation markers.--Antibodies to HIV.--Other antibodies.--Other serologic markers.--Antigen markers.--Cell surface T cell activation markers.--CD4+ T cells.--Discussion and recommendations.--Glossary.--References.
563 |aSoftcover
590 |a96-05|b1996-02-02
69007|aAIDS (disease)|2gcpds
7201 |aTsoukas, C. M.
77508|tLe rôle des marqueurs substituts de l'infection à VIH / |w(CaOODSP)9.679394
7760#|tThe role of surrogate markers of HIV infection : |w(CaOODSP)9.695832